echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Overview of global new crown drug development

    Overview of global new crown drug development

    • Last Update: 2022-06-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The new crown epidemic continues to rage, and pharmaceutical companies are also stepping up their efforts to develop anti-epidemic weapons


    As of April 13, a total of 986 drugs (including vaccines) have been developed for COVID-19 indications worldwide


    In terms of drug types, there are 360 ​​chemical drugs, 596 biological drugs, 19 traditional Chinese medicines and 11 other types of drugs


    From the perspective of research and development progress, 39 new crown products have been approved for listing, and another 6 have applied for listing


    From the perspective of layout companies, the company that has disclosed the most products related to COVID-19 indications is Roche (20), followed by AstraZeneca (19) and Pfizer (19).


    The domestic companies/institutions that disclosed the most products related to COVID-19 indications are Shanghai Institute of Materia Medica (8), Fosun Pharma (7), Ascletis Pharma (6) and Emmy Vaccine (6), and CMS Companies such as Pharmaceuticals, China Cell, Wuhan Institute of Virology, Danxu Bio, Innovent Bio, and Watson Bio have all deployed more than 3 projects on COVID-19 indications


    From the perspective of market returns, Pfizer is undoubtedly the biggest winner.


    The world is an organic whole that is universally connected.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.